CA2795856A1 — Coded cap for use with a drug delivery device
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2011-10-13 · 15y expired
What this patent protects
A cap-fit differentiation means for use with a medication or drug delivery device (100, 206) is described. The cap (106,200) includes at least one first coding feature located on a surface (204) of the cap (106, 200), the at least one coding feature configured to interact with at…
USPTO Abstract
A cap-fit differentiation means for use with a medication or drug delivery device (100, 206) is described. The cap (106,200) includes at least one first coding feature located on a surface (204) of the cap (106, 200), the at least one coding feature configured to interact with at least one second coding feature located on the drug delivery device (100, 206). When the first and second coding features interact, feedback is provided to a user. The feedback may include tactile and/or audible feedback. The second coding feature may alternatively be located on the cartridge (120) or cartridge holder (104).
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.